Cargando…

IGF2BP3-induced activation of EIF5B contributes to progression of hepatocellular carcinoma cells

In this study, we investigated the functional role of eukaryotic initiation factor 5B (EIF5B) in hepatocellular carcinoma (HCC) and the underlying mechanisms. Bioinformatics analysis demonstrated that the EIF5B transcript and protein levels as well as the EIF5Bcopy number were significantly higher i...

Descripción completa

Detalles Bibliográficos
Autores principales:	LI, XIAOYIN, WANG, QIAN, LIANG, HONGFENG, CHEN, SHISHENG, CHEN, HAIWEN, LU, YAOYONG, YANG, CHANGFU
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Tech Science Press 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207990/ https://www.ncbi.nlm.nih.gov/pubmed/37305324 http://dx.doi.org/10.32604/or.2022.026511

Ejemplares similares

Pan-cancer analysis identifies LPCATs family as a prognostic biomarker and validation of LPCAT4/WNT/β-catenin/c-JUN/ACSL3 in hepatocellular carcinoma
por: Lu, Yaoyong, et al.
Publicado: (2023)

LIN28B-AS1-IGF2BP1 binding promotes hepatocellular carcinoma cell progression
por: Zhang, Jian, et al.
Publicado: (2020)

Investigation of Igf-1, Igf-Bp3 and Igf-Bp5 levels in umbilical cord blood of infants with developmental dysplasia of the hip
por: DEMİREL, Esra, et al.
Publicado: (2023)

CircEIF3H-IGF2BP2-HuR scaffold complex promotes TNBC progression via stabilizing HSPD1/RBM8A/G3BP1 mRNA
por: Song, Xiaojin, et al.
Publicado: (2022)

N(6)-methyladenosine reader IGF2BP3 as a prognostic Biomarker contribute to malignant progression of glioma
por: Zheng, Xin, et al.
Publicado: (2023)

An isocorydine derivative (d-ICD) inhibits drug resistance by downregulating IGF2BP3 expression in hepatocellular carcinoma
por: Li, Meng, et al.
Publicado: (2015)

Activated 4E-BP1 represses tumourigenesis and IGF-I-mediated activation of the eIF4F complex in mesothelioma
por: Jacobson, B A, et al.
Publicado: (2009)

Targeting IGF2BP3 in Cancer
por: Liu, Xin, et al.
Publicado: (2023)

Anti-oncogene PTPN13 inactivation by hepatitis B virus X protein counteracts IGF2BP1 to promote hepatocellular carcinoma progression
por: Yan, Yongcong, et al.
Publicado: (2020)

RBM15 promotes hepatocellular carcinoma progression by regulating N6-methyladenosine modification of YES1 mRNA in an IGF2BP1-dependent manner
por: Cai, Xianlei, et al.
Publicado: (2021)

IGF2BP3 promotes progression of gallbladder carcinoma by stabilizing KLK5 mRNA in N(6)-methyladenosine-dependent binding
por: Zhang, Junzhe, et al.
Publicado: (2022)

Genome and transcriptome profiling of fibrolamellar hepatocellular carcinoma demonstrates p53 and IGF2BP1 dysregulation
por: Sorenson, Eric C., et al.
Publicado: (2017)

m(6)A modification of AC026356.1 facilitates hepatocellular carcinoma progression by regulating the IGF2BP1-IL11 axis
por: Wei, Huamei, et al.
Publicado: (2023)

MiR-216b is involved in pathogenesis and progression of hepatocellular carcinoma through HBx-miR-216b-IGF2BP2 signaling pathway
por: Liu, F-y, et al.
Publicado: (2015)

AHNAK Contributes to Hepatocellular Carcinoma Growth by Interacting with IGF-1R
por: Li, Kang, et al.
Publicado: (2022)

IGF2BP3 Enhances the Growth of Hepatocellular Carcinoma Tumors by Regulating the Properties of Macrophages and CD8(+) T Cells in the Tumor Microenvironment
por: Ma, Lingyu, et al.
Publicado: (2023)

IGF2BP2 acts as a m(6)A modification regulator in laryngeal squamous cell carcinoma through facilitating CDK6 mRNA stabilization
por: Tang, Xiaojun, et al.
Publicado: (2023)

Hsa_circ_0026134 expression promoted TRIM25- and IGF2BP3-mediated hepatocellular carcinoma cell proliferation and invasion via sponging miR-127-5p
por: Zhang, Wei, et al.
Publicado: (2020)

MicroRNA-98-5p Inhibits Cell Proliferation and Induces Cell Apoptosis in Hepatocellular Carcinoma via Targeting IGF2BP1
por: Jiang, Tinghui, et al.
Publicado: (2017)

4E-BP restrains eIF4E phosphorylation
por: Müller, David, et al.
Publicado: (2013)

eIF6 promotes the malignant progression of human hepatocellular carcinoma via the mTOR signaling pathway
por: Sun, Liping, et al.
Publicado: (2021)

Targeting EIF3C to suppress the development and progression of nasopharyngeal carcinoma
por: Zhao, Qian, et al.
Publicado: (2022)

IGF2BP3 May Contributes to Lung Tumorigenesis by Regulating the Alternative Splicing of PKM
por: Xueqing, Huang, et al.
Publicado: (2020)

METTL3 facilitates tumor progression via an m(6)A-IGF2BP2-dependent mechanism in colorectal carcinoma
por: Li, Ting, et al.
Publicado: (2019)

Methylation in MIRLET7A3 Gene Induces the Expression of IGF-II and Its mRNA Binding Proteins IGF2BP-2 and 3 in Hepatocellular Carcinoma
por: Waly, Amr A., et al.
Publicado: (2019)

The deubiquitinase EIF3H promotes hepatocellular carcinoma progression by stabilizing OGT and inhibiting ferroptosis
por: Tang, Jianing, et al.
Publicado: (2023)

Overexpression of IGF2BP3 as a Potential Oncogene in Ovarian Clear Cell Carcinoma
por: Liu, Huidi, et al.
Publicado: (2020)

LINC01001 Promotes Progression of Crizotinib-Resistant NSCLC by Modulating IGF2BP2/MYC Axis
por: Zhang, Meiling, et al.
Publicado: (2021)

IGF-1 induces the epithelial-mesenchymal transition via Stat5 in hepatocellular carcinoma
por: Zhao, Chuanzong, et al.
Publicado: (2017)

IGF2BP2 promotes colorectal cancer progression by upregulating the expression of TFRC and enhancing iron metabolism
por: Liu, Tian-yue, et al.
Publicado: (2023)

IGF2BP2 maybe a novel prognostic biomarker in oral squamous cell carcinoma
por: Wang, Xiangpu, et al.
Publicado: (2022)

Circular RNA circEYA3 promotes the radiation resistance of hepatocellular carcinoma via the IGF2BP2/DTX3L axis
por: Hu, Pan, et al.
Publicado: (2023)

IGF2BP1 is the first positive marker for anaplastic thyroid carcinoma diagnosis
por: Haase, Jacob, et al.
Publicado: (2020)

CHRNA5 Contributes to Hepatocellular Carcinoma Progression by Regulating YAP Activity
por: Fu, Yan, et al.
Publicado: (2022)

EIF4EBP1 Overexpression Is Associated with Poor Survival and Disease Progression in Patients with Hepatocellular Carcinoma
por: Cha, Yin-Lian, et al.
Publicado: (2015)

EIF5A expression and its role as a potential diagnostic biomarker in hepatocellular carcinoma
por: Li, Linjing, et al.
Publicado: (2021)

TMEM44-AS1 promotes esophageal squamous cell carcinoma progression by regulating the IGF2BP2-GPX4 axis in modulating ferroptosis
por: Yang, Ruotong, et al.
Publicado: (2023)

eIF4E-eIF4G complex inhibition synergistically enhances the effect of sorafenib in hepatocellular carcinoma
por: Fang, Chao, et al.
Publicado: (2021)

EIF4A3-induced circTOLLIP promotes the progression of hepatocellular carcinoma via the miR-516a-5p/PBX3/EMT pathway
por: Liu, Yachong, et al.
Publicado: (2022)

Identification of an IGF2BP2-Targeted Peptide for Near-Infrared Imaging of Esophageal Squamous Cell Carcinoma
por: Shu, Wenbin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bdhcjtl714kl5h84mbkgpjnn7g